Oncotelic Therapeutics, Inc. (OTLC) has a market capitalization of $16.02M and trades at $0.04. The 52-week range is 0.02-0.11.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.6, Earnings Per Share (EPS) of $-0.01.
The stock has a beta of -0.59, operates in the Healthcare sector.